Combined Podcast (NASW credit)

Combined Podcast for Social Workers (NASW credit)

Activity Details
  • Credit Amounts:
    • Other: 1.50
    • NASW: 1.50
  • Cost: Free
  • Release: May 26, 2020
  • Expires: May 31, 2021
  • Estimated Time to Complete:
    1 Hour(s)  30 Minutes
  • System Requirements:
  • Average User Rating:
    ( Ratings)

Faculty

Katherine E.  Galluzzi Katherine E. Galluzzi, DO, CMD, FACOFP DIST
Professor and Chair, Geriatric
and Palliative Medicine
Director, Comprehensive Care.
Philadelphia College of Osteopathic Medicine
Medical Director
VNA Hospice of Philadelphia
Philadelphia, Pennsylvania

Keela Herr Keela Herr, PhD, RN, AGSF, FGSA, FAAN
Kelting Professor, Nursing
Associate Dean, Faculty
Co-Director
Csomay Center for Gerontological Excellence
University of Iowa College of Nursing
Iowa City, Iowa

Needs Statement

PAIN COACH is based on the revised FDA's Opioid Analgesic REMS Education Blueprint for Health Care Providers Involved in the Treatment and monitoring of Patients with Pain to increase the knowledge, confidence, and competence of physicians and other healthcare providers involved in the treatment of pain in older adults.

The four-part enduring podcast series delivers the FDA Blueprint educational material to learners in 15-minute increments. Learners who complete the podcast series will be invited to participate in one of the live workshops, which will provide supplemental information on the management of pain in older adults via a short, didactic presentation, case-based clinical questions, and patient-provider role-play to demonstrate the concepts covered in the didactic material and reinforce the FDA Blueprint.

Target Audience

This activity is designed for prescribers and dispensers of controlled substances including physicians, physician assistants, pharmacists, nurse practitioners, dentists, and any other interested healthcare professionals such as social workers and public health professionals.

Objectives

Upon completion of this education activity, participants will be able to:

  • Discuss fundamental concepts of pain management, including definitions, and mechanisms of pain
  • Describe how to assess patients in pain
  • Identify risk factors for abuse and addiction
  • Describe the range of therapeutic options for managing pain, including nonpharmacologic approaches and pharmacologic (non-opioid and opioid analgesics) therapies
  • Integrate opioid analgesics into a pain treatment plan individualized to the needs of the patient
  • Discuss how to safely and effectively manage patients on opioid analgesics in the acute and chronic pain settings, including initiating therapy, titrating, and discontinuing use of opioid analgesics
  • Describe how to counsel patients and caregivers about the safe use of opioid analgesics, including proper storage and disposal
  • Relate how to counsel patients and caregivers about the use of naloxone for opioid overdose
  • Discuss when referral to a pain specialist is appropriate
  • Describe the fundamental elements of addiction medicine
  • Identify patients with opioid use disorder
  • Manage patients with opioid use disorder

Accreditation

Other
UK Healthcare CECentral certifies this activity for 1.50 hours of participation.

NASW

This program is Approved by the National Association of Social Workers (Approval #886828917-4985) for 1.50 continuing education contact hours.

Faculty Disclosure

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see   https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration.

No speakers, planners, or content reviewers have any relevant financial relationships to disclose. 

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Acknowledgment

This activity is jointly provided by the University of Kentucky and The France Foundation.

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies.

CE Content Concerns

Policy

Concerns or complaints related to ACPE or ACCME standards may be submitted in writing to the Director of UK HealthCare CECentral by fax to 859-323-2920, or by mail to 2365 Harrodsburg Road, Ste B475, Lexington, KY 40504

Procedures

  • The Director or his/her designee will review, investigate, forward and/or respond to complaints and will put forth a best effort to adjudicate the issue(s), along with CECentral staff members, within two (2) weeks of receipt of the grievance or complaint.
  • If needed, concerns, complaints, or grievances will be brought before the UK HealthCare CECentral Advisory Board.
  • Issues regarding activity content also will be reviewed and addressed by the Activity Director.
  • A written decision will be issued in a timely manner by the Director of UK HealthCare CECentral or his/herdesignee.
  • Grievances will be considered when planning future activities.

Appeal Procedure

  • Persons who wish to appeal a decision should address the appeal by email, fax or in writing to the Director of UK HealthCare CECentral within two (2) weeks of receipt of the response.
  • The Director will bring the appeal to the UK HealthCare CECentral Advisory Board.
  • The results of the appeal will be sent to the participant no later than two (2) weeks following the meeting of the board.